CVS Health CVS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 179.4%+8.4pp | 171.1%+14.9pp | 156.2%-1.3pp | 157.5%-1.0pp | |
| Operating margin | 7.3%-4.5pp | 11.8%-0.4pp | 12.1%-1.3pp | 13.4%-6.0pp | |
| Net margin | 3.1%-3.5pp | 6.6%-0.3pp | 6.9%-0.9pp | 7.8%-2.9pp | |
| Returns | |||||
| Return on equity | 15.9%-16.7pp | 32.6%-0.2pp | 32.8%-0.2pp | 33.1%-9.7pp | |
| Return on invested capital | 19.2%-4.7pp | 23.9%+0.3pp | 23.7%-6.3pp | 30%-2.0pp | |
| Efficiency | |||||
| Asset turnover | 6.2×+0.3× | 5.9×+0.1× | 5.8×+0.4× | 5.4×+0.5× | |
| Liquidity | |||||
| Current ratio | 3.3×0.0× | 3.3×-0.2× | 3.5×-0.2× | 3.7×0.0× | |
| Leverage | |||||
| Debt-to-equity | 1.9×-1.8× | 3.7×-0.7× | 4.4×+1.1× | 3.3×+0.6× | |
| Net debt / EBITDA | 9.8×-6.5× | 16.3×-3.3× | 19.6×+5.8× | 13.8×+5.3× | |
| Per Share | |||||
| Book value per share | $238.44+0.5% | $237.30+3.8% | $228.70+3.8% | $220.28-0.4% | |
| Valuation | |||||
| Market capitalization | $367.27B+18.4% | $310.11B-17.4% | $375.34B-25.2% | $502B+9.7% | |
| Price / earnings | 295.9×+244× | 52×-23.7× | 75.8×-20.6× | 96.4×+35.8× | |
| Price / sales | 0.9×+0.1× | 0.8×-0.2× | 1.1×-0.5× | 1.6×0.0× | |
| Price / book | 4.9×+0.7× | 4.1×-0.9× | 5.1×-1.8× | 6.9×+0.7× | |
| EV / EBITDA | 43×+6.5× | 36.5×-9.9× | 46.4×-3.2× | 49.6×+15.8× | |
| Dividend yield | 14.8%-2.9pp | 17.7%+4.7pp | 13%+4.1pp | 9%-0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CVS Health's profit margins?
- CVS Health (CVS) runs a 44.7% gross margin and a 1.5% operating margin, with a 0.7% net margin.
- Where do CVS Health's ratios come from?
- Every ratio is computed from CVS Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
